|
10 Jan 2023
|
Pharmaceuticals & Biotech.
|
Axis Direct
|
|
|
|
|
Sector Update
|
|
|
Pharma - Q3FY23 - Earnings Preview
|
|
17 Nov 2022
|
Pharmaceuticals & Biotech.
|
Trendlyne Analysis
|
|
|
|
|
Sector Update
|
|
|
Indian drug formulation companies are adapting to the fast-changing dynamics of the pharma industry. Top-listed players have been making their bets and changing the pattern of their capital allocation in the past two years.
|
|
14 Oct 2022
|
Pharmaceuticals & Biotech.
|
KRChoksey
|
|
|
|
|
Sector Update
|
|
|
Indian Pharma Market (IPM) sustained healthy sales growth for four consecutive months from June 22 to September 22.
|
|
13 Oct 2022
|
Pharmaceuticals & Biotech.
|
ICICI Securities Limited
|
|
|
|
|
Sector Update
|
|
|
We expect pharma and healthcare companies under our coverage to report modest growth in Q2FY23 with domestic market supported by demand despite high base.
|
|
11 Oct 2022
|
Pharmaceuticals & Biotech.
|
Axis Direct
|
|
|
|
|
Sector Update
|
|
|
PHARMA Q2FY23 PREVIEW
|
|
10 Oct 2022
|
Pharmaceuticals & Biotech.
|
ICICI Direct
|
|
|
|
|
Sector Update
|
|
|
|
|
14 Sep 2022
|
Pharmaceuticals & Biotech.
|
ICICI Securities Limited
|
|
|
|
|
Sector Update
|
|
|
The Ministry of Health and Family Welfare has released an updated national list of essential medicines (NLEM) which includes 384 drugs across different therapies.
|
|
12 Jul 2022
|
Pharmaceuticals & Biotech.
|
ICICI Direct
|
|
|
|
|
Sector Update
|
|
|
|
|
27 Jun 2022
|
Pharmaceuticals & Biotech.
|
ICICI Direct
|
|
|
|
|
Sector Update
|
|
|
|
|
13 Jun 2022
|
Pharmaceuticals & Biotech.
|
BOB Capital Markets Ltd.
|
|
|
|
|
Sector Update
|
|
|
Managements of DRRD, ARBP and LAURUS confident of near-term growth drivers but see many moving parts in long run
|